| |
| |
|
| Insider
Information: |
Riedel Norbert G |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
854,950 |
|
|
Indirect Shares
|
740,608 |
|
|
| Direct
Value |
$5,847,325 |
|
|
|
Indirect Value
|
$71,098 |
|
|
| Total
Shares |
1,595,558 |
|
|
| Total
Value |
$5,918,423 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -38.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Baxter International Inc |
BAX |
Corporate Vice President |
2013-01-16 |
56,689 |
2005-03-14 |
0 |
Premium* |
|
|
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
2008-06-12 |
1,340 |
2006-06-08 |
0 |
Premium* |
|
|
Ariad Pharmaceuticals Inc |
ARIA |
Director |
2016-02-01 |
121,859 |
2011-04-28 |
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
13,705 |
2013-05-09 |
0 |
Premium* |
|
|
Aptinyx Inc. |
APTX |
|
2021-12-06 |
615,265 |
2021-12-06 |
740,608 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2023-06-07 |
46,092 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2023-08-14 |
4 |
S |
$138.16 |
$171,454 |
D/D |
(1,241) |
13,705 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,075 |
14,946 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,282 |
46,092 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2022-08-08 |
4 |
S |
$152.32 |
$165,877 |
D/D |
(1,089) |
11,871 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,561 |
12,960 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2022-08-05 |
4 |
S |
$155.87 |
$1,246,920 |
D/D |
(8,000) |
10,399 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2022-08-05 |
4 |
OE |
$55.28 |
$442,240 |
D/D |
8,000 |
18,399 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2022-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,270 |
42,810 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO |
• • – |
2021-12-06 |
4 |
B |
$2.23 |
$223,000 |
I/I |
100,000 |
100,000 |
0.01 |
% |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2021-08-06 |
4 |
S |
$147.96 |
$193,236 |
D/D |
(1,306) |
10,399 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2021-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,246 |
11,705 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO |
• • – |
2021-05-17 |
4 |
D |
$2.53 |
$322,003 |
D/D |
(127,274) |
615,265 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO |
• • – |
2021-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
380,000 |
742,539 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2021-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,270 |
28,540 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2020-10-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,270 |
|
% |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2020-08-07 |
4 |
S |
$125.87 |
$117,186 |
D/D |
(931) |
9,459 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2020-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,705 |
10,390 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO and President |
• • – |
2020-01-10 |
4 |
B |
$3.00 |
$105,000 |
I/I |
35,000 |
35,000 |
2.66 |
% |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2019-08-09 |
4 |
S |
$135.65 |
$98,482 |
D/D |
(726) |
7,685 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2019-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
8,411 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO and President |
• • – |
2018-11-12 |
4 |
OE |
$2.59 |
$99,878 |
D/D |
38,563 |
362,539 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2018-08-10 |
4 |
S |
$176.61 |
$116,563 |
D/D |
(660) |
6,491 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2018-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,495 |
7,151 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
CEO and President |
• • – |
2018-06-25 |
4 |
B |
$16.00 |
$38,400 |
I/I |
2,400 |
5,118 |
2.66 |
- |
|
| APTX |
Aptinyx Inc. |
CEO and President |
• • – |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
2,718 |
2,718 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
